NCT00397098 - Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder | Biotech Hunter

Enrollment

257

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

Anxiety Disorders

Interventions

DRUG

SR58611A

Trial Locations (9)

Sanofi-Aventis Administrative Office, Macquarie Park

Sanofi-Aventis Administrative Office, Santiago

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Budapest

Sanofi-Aventis Administrative Office, Milan

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Barcelona